This company listing is no longer active
DBV Technologies Management
Management criteria checks 3/4
Key information
Daniel Tassé
Chief executive officer
US$2.4m
Total compensation
| CEO salary percentage | 24.7% |
| CEO tenure | 3.8yrs |
| CEO ownership | n/a |
| Management average tenure | 3.3yrs |
| Board average tenure | 3.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -US$77m |
| Mar 31 2022 | n/a | n/a | -US$85m |
| Dec 31 2021 | US$2m | US$600k | -US$98m |
| Sep 30 2021 | n/a | n/a | -US$124m |
| Jun 30 2021 | n/a | n/a | -US$131m |
| Mar 31 2021 | n/a | n/a | -US$148m |
| Dec 31 2020 | US$2m | US$600k | -US$160m |
| Sep 30 2020 | n/a | n/a | -US$161m |
| Jun 30 2020 | n/a | n/a | -US$171m |
| Mar 31 2020 | n/a | n/a | -US$169m |
| Dec 31 2019 | US$3m | US$600k | -US$172m |
| Sep 30 2019 | n/a | n/a | -US$176m |
| Jun 30 2019 | n/a | n/a | -US$198m |
| Mar 31 2019 | n/a | n/a | -US$191m |
| Dec 31 2018 | US$5m | US$55k | -US$190m |
Compensation vs Market: Daniel's total compensation ($USD2.43M) is about average for companies of similar size in the US market ($USD2.79M).
Compensation vs Earnings: Daniel's compensation has increased whilst the company is unprofitable.
CEO
Daniel Tassé (62 yo)
3.8yrs
Tenure
US$2,430,966
Compensation
Mr. Daniel Tasse had been an Independent Non-Executive Director of Indivior PLC since August 2014 until May 6, 2021 and Senior Independent Director since September 30, 2016 until May 6, 2021. Mr. Tasse ser...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.8yrs | US$2.43m | no data | |
| Chief Financial Officer | 1.8yrs | US$612.09k | 0.020% $ 93.1k | |
| Chief Medical Officer | 3.1yrs | US$1.20m | 0.0042% $ 19.7k | |
| Chief Technical Operations Officer & Chief Quality Officer | 2.3yrs | no data | no data | |
| Head of Investor Relations | no data | no data | no data | |
| Chief Legal Officer | 1.5yrs | no data | no data | |
| Vice President of Global Corporate Communications | no data | no data | no data | |
| Chief Human Resources Officer & Chief of Staff | 2.9yrs | no data | no data | |
| Chief Clinical Trial Officer & Senior VP | 6.3yrs | no data | no data | |
| Senior VP & Deputy CSO | 6.3yrs | no data | no data | |
| Senior Vice President of Commercial Operations North America | 6.6yrs | no data | no data | |
| Senior VP & Head of Global Regulatory Affairs | 3.6yrs | no data | no data |
3.3yrs
Average Tenure
54yo
Average Age
Experienced Management: DBVT.F's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.4yrs | US$2.43m | no data | |
| Independent Non-Executive Chairman | 4.3yrs | US$240.63k | 0.025% $ 119.9k | |
| Director | 6.8yrs | US$118.92k | 0% $ 0 | |
| Independent Director | 7.4yrs | US$160.33k | 0.0054% $ 25.4k | |
| Director | 6.2yrs | no data | no data | |
| Scientific Adviser to the CEO & Chairman of Scientific Advisory Board | 1.7yrs | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 3.3yrs | no data | no data | |
| Independent Director | 3.3yrs | US$159.15k | 0.00065% $ 3.1k | |
| Director | 5.2yrs | US$104.86k | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.3yrs | no data | no data |
3.4yrs
Average Tenure
62yo
Average Age
Experienced Board: DBVT.F's board of directors are considered experienced (3.4 years average tenure).